Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Ossowski

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
World Journal of Gastroenterology|January 10, 2015
Fatty acid changes help to better understand regression of nonalcoholic fatty liver diseaseDominika Maciejewska, Arleta Drozd, Piotr Ossowski, et al.
Prostaglandins & Other Lipid Mediators|September 27, 2015
Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot studyDominika Maciejewska, Piotr Ossowski, Arleta Drozd, et al.
Journal of Clinical Medicine|January 10, 2026
Dynamics of Haemostatic and Inflammatory Biomarkers in Patients with Combat-Related Injuries to Major Joints Before and After Surgical TreatmentStanislav Bondarenko, Alfonso Alías Petralanda, Yuriy Prudnikov, et al.
Postepy Dermatologii I Alergologii|November 29, 2023
Influence of adalimumab on interleukin 12/23 signalling pathways in human keratinocytes treated with lipopolysaccharide APaulina Buda, Piotr Michalski, Oliwia Warmusz, et al.
Frontiers in Oncology|January 24, 2025
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Frontiers in Oncology|April 23, 2025
Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Biomedicines|October 26, 2024
Evaluation of Selenium Concentrations in Patients with Crohn's Disease and Ulcerative ColitisMichał Chalcarz, Beniamin Oskar Grabarek, Tomasz Sirek, et al.
Breast Cancer Research and Treatment|May 27, 2025
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypesAgata Sirek, Tomasz Sirek, Robert Nowakowski, et al.
Biomedicines|December 30, 2025
Subtype-Independent Dysregulation of the Notch Signaling Pathway and Its miRNA Regulators in Breast CancerElżbieta Mitka-Krysiak, Katarzyna Król-Jatręga, Piotr Ossowski, et al.
Frontiers in Molecular Biosciences|March 20, 2026
Integrated transcriptomic, protein, and MicroRNA profiling reveals a conserved pyroptosis-related molecular signature across breast cancer subtypesAgata Panfil, Tomasz Sirek, Agata Sirek, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
World Journal of Gastroenterology|January 10, 2015
Fatty acid changes help to better understand regression of nonalcoholic fatty liver diseaseDominika Maciejewska, Arleta Drozd, Piotr Ossowski, et al.
Prostaglandins & Other Lipid Mediators|September 27, 2015
Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot studyDominika Maciejewska, Piotr Ossowski, Arleta Drozd, et al.
Journal of Clinical Medicine|January 10, 2026
Dynamics of Haemostatic and Inflammatory Biomarkers in Patients with Combat-Related Injuries to Major Joints Before and After Surgical TreatmentStanislav Bondarenko, Alfonso Alías Petralanda, Yuriy Prudnikov, et al.
Postepy Dermatologii I Alergologii|November 29, 2023
Influence of adalimumab on interleukin 12/23 signalling pathways in human keratinocytes treated with lipopolysaccharide APaulina Buda, Piotr Michalski, Oliwia Warmusz, et al.
Frontiers in Oncology|January 24, 2025
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Frontiers in Oncology|April 23, 2025
Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targetsTomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Biomedicines|October 26, 2024
Evaluation of Selenium Concentrations in Patients with Crohn's Disease and Ulcerative ColitisMichał Chalcarz, Beniamin Oskar Grabarek, Tomasz Sirek, et al.
Breast Cancer Research and Treatment|May 27, 2025
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypesAgata Sirek, Tomasz Sirek, Robert Nowakowski, et al.
Biomedicines|December 30, 2025
Subtype-Independent Dysregulation of the Notch Signaling Pathway and Its miRNA Regulators in Breast CancerElżbieta Mitka-Krysiak, Katarzyna Król-Jatręga, Piotr Ossowski, et al.
Frontiers in Molecular Biosciences|March 20, 2026
Integrated transcriptomic, protein, and MicroRNA profiling reveals a conserved pyroptosis-related molecular signature across breast cancer subtypesAgata Panfil, Tomasz Sirek, Agata Sirek, et al.
Pageof 4